Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · Real-Time Price · USD
0.740
+0.058 (8.54%)
At close: Jan 21, 2025, 4:00 PM
0.743
+0.003 (0.41%)
After-hours: Jan 21, 2025, 7:59 PM EST
Cognition Therapeutics Market Cap
Cognition Therapeutics has a market cap or net worth of $30.75 million as of January 21, 2025. Its market cap has decreased by -49.62% in one year.
Market Cap
30.75M
Enterprise Value
9.31M
1-Year Change
-49.62%
Ranking
Category
Stock Price
$0.74
Market Cap Chart
Since the IPO on October 8, 2021, Cognition Therapeutics's market cap has decreased from $256.46M to $30.75M, a decrease of -88.01%. That is a compound annual growth rate of -47.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 28.33M | -2.78% |
| Dec 31, 2024 | 29.14M | -50.97% |
| Dec 29, 2023 | 59.43M | -2.39% |
| Dec 30, 2022 | 60.88M | -56.29% |
| Dec 31, 2021 | 139.27M | -45.69% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |